Skip to main content
Rapid Dose Therapeutics Corp logo

Rapid Dose Therapeutics Corp — Investor Relations & Filings

Ticker · DOSE ISIN · CA75339A1012 CSE Manufacturing
Open in API
Filings indexed 490 across all filing types
Latest filing 2024-06-25 Capital/Financing Update
Country CA Canada
Listing CSE DOSE

About Rapid Dose Therapeutics Corp

https://rapid-dose.com/

Rapid Dose Therapeutics Corp. is a pharma-technology company specializing in proprietary drug delivery technologies engineered to enhance patient outcomes and quality of life. The core business revolves around an innovative oral delivery platform utilizing sublingual thin film strip technology. The company's flagship product, QuickStrip™, is a fast-dissolving system designed for the rapid release of pharmaceuticals, micronized oils, and over-the-counter medicines. QuickStrip™ is distinguished by its ability to achieve blood concentrations comparable to intravenous injection, offering superior bioavailability and rapid onset. RDT provides product innovation, production, and consultation services to the pharmaceutical and healthcare manufacturing sectors for both prescription and non-prescription applications.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a press release announcing the receipt of a research grant (Mitacs Accelerate grant) for a vaccine delivery study by Rapid Dose Therapeutics Corp. It discusses the research project, funding amounts, and the technology involved. There are no financial statements, regulatory filings, voting results, or management changes. The content is focused on a research grant award and project update, which is a typical capital/financing update or funding announcement. It is not an annual report, earnings release, or any other detailed financial or governance report. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length (6936 characters) and content confirm it is not a brief announcement or a report publication notice but a substantive update on financing activity related to research funding.
2024-06-25 English
News release - English.pdf
Regulatory Filings
2024-06-19 English
Material change report - English.pdf
Capital/Financing Update Classification · 95% confidence The document is titled 'FORM 51-102F3 MATERIAL CHANGE REPORT' and details a material change event dated May 16, 2024, involving the closing of a fifth tranche of a private placement financing by Rapid Dose Therapeutics Corp. The content includes specifics about the private placement, such as the number of units issued, warrants, commissions paid, and intended use of proceeds. This is a clear announcement of a financing event and capital raising activity. There is no indication that this is a full financial report, audit, or earnings release. The document is not a proxy, AGM material, or management discussion. It is a regulatory filing announcing a material change related to capital raising. According to the filing definitions, updates on company fundraising or financing activities fall under 'Capital/Financing Update' (CAP). The document length is substantial and contains detailed information about the financing, not just a brief announcement or a link to a report, so it is not a Report Publication Announcement (RPA) or Regulatory Filing (RNS) fallback. Therefore, the correct classification is CAP with high confidence.
2024-05-24 English
Report of exempt distribution (45-106F1).pdf
Regulatory Filings Classification · 95% confidence The document is a news release from SPARC AI INC. announcing the selection of a specific drone model for integration with their microchip technology. It contains no financial data, no regulatory form references, no fiscal period reporting, and no mention of shareholder meetings, voting, or management changes. It is a corporate announcement about a product integration and testing plan. The document is approximately 5,316 characters, which is relatively short and reads like a press release rather than a financial or regulatory filing. There is no indication that this is a report or an announcement of a report publication. It does not fit into categories like Annual Report, Earnings Release, or Regulatory Filings. The content is best classified as a general corporate news release, which falls under Regulatory Filings (RNS) as a fallback category for miscellaneous announcements that do not fit other specific categories.
2024-05-24 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing the publication of a research project result in a scientific journal. It discusses a collaborative research project between Rapid Dose Therapeutics and McMaster University, focusing on drug delivery technology. There is no indication of financial data, regulatory filings, management changes, or shareholder information. The document is not a financial report, earnings release, or any regulatory filing. It is an announcement of a research publication and company innovation, which does not fit into any of the specific financial or regulatory filing categories. Therefore, the best fit is Regulatory Filings (RNS) as a general announcement that does not fit other categories.
2024-05-22 English
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a press release announcing the closing of a tranche of a private placement financing by Rapid Dose Therapeutics Corp. It details the amount raised, the number of units issued, the terms of the units and warrants, commissions paid to agents, and intended use of proceeds. There is no financial statement or detailed financial analysis present. The document is an update on capital raising activity, specifically a private placement financing. This fits the definition of a Capital/Financing Update (CAP). The document length is about 6,492 characters, which is consistent with a detailed announcement but not a full financial report. Therefore, the correct classification is CAP with high confidence.
2024-05-17 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.